Bristol Myers to Prolong Crucial Cobenfy Trial in Alzheimer’s Psychosis Following Discovery of 'Irregularities'

Bristol Myers to Prolong Crucial Cobenfy Trial in Alzheimer’s Psychosis Following Discovery of ‘Irregularities’

Bristol Myers to Prolong Crucial Cobenfy Trial in Alzheimer’s Psychosis Following Discovery of 'Irregularities'